| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |